Page 164 - Profile's Stock Exchange Handbook 2022 Issue 1
P. 164

JSE – MED                                Profile’s Stock Exchange Handbook: 2022 – Issue 1
                                                  Fixed Ass     4 218  4 052  4 358  3 524  3 590
             Mediclinic International plc         Inv in Assoc   166  171   181   193  357
        MED                                       Inv & Loans    17    12    9    10     7
       ISIN: GB00B8HX8Z88
       SHORT: MEDICLINIC                          Def Tax Asset  29    34    22   22    22
       CODE: MEI                                  Tot Curr Ass  1 363  1 232  1 213  1 091  961
       REG NO: 08338604                           Ord SH Int    3 040  2 849  2 890  3 151  3 286
       FOUNDED: 1983                              Minority Int   120  118   113   115   87
       LISTED: 1986                               LT Liab       3 139  3 021  3 182  2 576  2 445
                                                  Tot Curr Liab  724  684   769   584  525
        NATURE OF BUSINESS:                       PER SHARE STATISTICS (cents per share)
        Mediclinic is a diversified international private healthcare  EPS (ZARc)  175.56  195.96  - 814.18  - 369.21 - 1 148.57
        services group, founded in South Africa in 1983, with divisions  HEPS-C (ZARc)  175.56  204.48  504.64  515.09  475.27
        in Switzerland, Southern Africa (South Africa and Namibia),  Pct chng p.a.  71.7  - 59.5  - 2.0  8.4  - 16.7
        and the United Arab Emirates. The Group's core purpose is to  Tr 5yr av grwth %  -  - 15.4  1.9  5.7  79.3
                                                  DPS (ZARc)      -     -  60.83  145.41  139.39
        enhance the quality of life. Its vision is to be the partner of
                                                                                        4.1
                                                                                  4.3
        choice that people trust for all their healthcare needs.  Pct chng p.a.  - -  - 100.0  - 58.2  10.3  11.8
                                                                     - 32.7
                                                                            - 3.5
                                                   Tr 5yr av grwth %
        Mediclinic is focused on providing specialist-orientated,  NAV PS (ZARc)  8 387.61 7 872.19 8 655.36 8 372.73 7 581.02
        multi-disciplinaryservicesacrossthecontinuumofcareinsuch  3 Yr Beta  0.49  0.73  1.05  1.19  0.98
        away thattheGroup willberegarded as themostrespected and  Price High  6 797  7 019  8 043  12 023  15 261
        trusted provider of healthcare services by patients, medical  Price Low  5 541  5 250  5 157  5 199  8 810
        practitioners, funders and regulators of healthcare in each of its  Price Prd End  6 372  5 815  5 729  5 699  10 015
                                                  RATIOS
        markets.                                  Ret on SH Fnd  4.62  2.66  - 9.96  - 3.98  - 14.05
        At 30 September 2021, Mediclinic comprised 74 hospitals, 5  Ret On Tot Ass  3.06  0.78  - 4.58  - 2.02  - 7.47
        sub-acute and 2 mental health facilities, 19 day case clinics, and  Oper Pft Mgn  8.16  6.98  - 5.97  2.76  - 10.01
        20 outpatient clinics. Hirslanden operated 17 hospitals and  D:E  1.03  1.05  1.11  0.53  0.50
        four day case clinics in Switzerland with around 1 900 inpatient  Int Cover  3.91  2.83  n/a  n/a  n/a
                                                                            1.58
                                                                                       1.83
                                                                                 1.87
        beds; Mediclinic Southern Africa operations included 50  Current Ratio  1.88 -  1.80 -  - 13.38  - 2.20  - 8.17
                                                  Div Cover
        hospitals (three of which in Namibia), 5 sub-acute hospitals, 2  NUMBER OF EMPLOYEES: 33 100+
        mental health facilities and 13 day case clinics (four of which  DIRECTORS: Beale Dame I K (Chair, ind ne, UK),
        operated by Intercare) across South Africa, and around 8 600  van der Merwe Dr C A (CEO), Myburgh P J (CFO),
        inpatient beds; and Mediclinic Middle East operated seven  Al HashimiDrMY(ind ne, Emirati),
                                                               Barsegiyan N (ind ne, Fr and Russ), Durand JJ(ne),
        hospitals, two day case clinics and 20 outpatient clinics with  Grieve JA(ne, UK and Swiss),
        around 1 000 inpatient beds in the UAE. In addition, under a  Harvey Dr F A H (snr ind ne, UK), Meintjes D P (ne),
        management contract Mediclinic Middle East operates one  Oswald Dr A (ind ne, Swiss), Petersen T D (ne),
                                                               Singer TD(ind ne, UK), Weiner S R (ind ne, USA),
        hospital in Abu Dhabi and will open a 200-bed hospital in the  UysPJ(alt)
        Kingdom of Saudi Arabia in mid-2022.      Scan the QR code to  POPULAR BRAND NAMES: ER24, Hirslanden,
                                                   visit our website  Medical  Innovations,  Mediclinic,  Mediclinic
        The Company's primary listing is on the London Stock   Middle East, MHR
        Exchange ("LSE") in the United Kingdom, with secondary  POSTAL ADDRESS: PO Box 456, Stellenbosch, 7599, South Africa
        listings on the JSE in South Africa and the Namibian Stock  EMAIL: info@mediclinic.com
        Exchange in Namibia.                      WEBSITE: www.mediclinic.com
        Mediclinic also holds a 29.9% interest in Spire Healthcare  TELEPHONE: 021-809-6500
                                                  COMPANY SECRETARY: Link Company Matters Ltd.
        Groupplc,a leading private healthcare groupbased in the  TRANSFER SECRETARY: Computershare Investor Services (Pty) Ltd.
        United Kingdom and listed on the LSE.     SPONSORS: Morgan Stanley & Co International plc (UK), Rand Merchant
        Mediclinic also has many strategic partnerships, including:  Bank (A division of FirstRand Bank Ltd. (SA)), Simonis Storm Securities
                                                   (Pty) Ltd., UBS Investment Bank (UK)
        Switzerland                               AUDITORS: PwC LLP
        *Medbase
        *Various leading private and public healthcare institutions  CALENDAR  Expected  Status
        South Africa                              Next Final Results   25 May 2022  Confirmed
        *Medical Innovations - procurer and manufacturer of hospital  Annual General Meeting  28 Jul 2022  Confirmed
        equipment                                 Next Interim Results  16 Nov 2022  Confirmed
        *MHR - recruitment of temporary and permanent staff across  CAPITAL STRUCTURE  AUTHORISED  ISSUED
        all sectors of the healthcare industry    MEI  Ords 10p ea            -    737 243 810
        *ER24 - emergency medical transport services  DISTRIBUTIONS [GBPp]
        *Icon Oncology – cancer treatment provider  Ords 10p ea         Ldt     Pay    Amt
        United Arab Emirates                      Interim No 13      3 Dec 19  17 Dec 19  3.20
                                                                             29 Jul 19
        *Bourn Hall MENA – UAE-based fertility centre  Final No 12   11 Jun 19  18 Dec 18  4.70
                                                                                       3.20
                                                                     4 Dec 18
                                                  Interim No 11
        *Various leading tertiary institutions    Final No 10        12 Jun 18  30 Jul 18  4.70
        Kingdom of Saudi Arabia                   LIQUIDITY: Nov21 Avg 4m shares p.w., R257.1m(29.3% p.a.)
        *Al Murjan Group – leading business investment group
                                                            40 Week MA        MEDICLINIC
       SECTOR: HlthCare—HtlhCare—HlthCarePrvdrs—HlthCareFacilities
       MAJOR ORDINARY SHAREHOLDERS as at 22 Sep 2021
         Remgro                           44.56%                                       17953
         Public Investment Corporation SOC Ltd.  10.09%
         Genesis Investment Management LLP  5.01%                                      14815
       FINANCIAL STATISTICS
       (GBP million)  Sep 21  Mar 21  Mar 20  Mar 19  Mar 18                           11676
                   Interim  Final  Final  Final  Final
                                                                                       8538
       Turnover      1 581  2 995  3 083  2 932  2 876
       Op Inc         129  209  - 184  81   - 288                                      5400
                                                     2016  |  2017  |  2018  |  2019  |  2020  |  2021
       NetIntPd(Rcvd)  33   95    83   57    85
       Tax            18    25    24   - 7   - 5  Recent Announcements
       Minority Int    8    11    21   21    18   Friday, 19 November 2021: Pursuant to Listing Rule 9.6.14 (2), the
       Att Inc        65    68  - 320  - 151  - 492  Company announces that Dame Inga Beale, Non-executive Chair
       TotCompIncLoss  203  - 29  - 151  - 22  - 723  of Mediclinic, has been appointed as a director of Willis Towers
       Hline Erngs-CO  65   71   198   211  203
                                                   Watson PLC with effect from 1 January 2022.
                                               162
   159   160   161   162   163   164   165   166   167   168   169